3ENGBER TM, DENNIS SA, JONES BE, et al. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine[J] . Neuroscience, 1998, 87(4):905-911.
4L1N JS, HOU Y, JOUVER M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidence by c-fos immunocytochemistry in the cat[J]. Proc NatI Acad Sci USA , 1996,93(24) :14128-14133.
5HOU YP, LIN ,IS. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats[ J ]. Aeta Pharmacol Sin, 1999,20(9) :813 - 818.
6ROBERTSON P, DECORY HH,MADAN A,et al. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil[ J ]. Drug Metab Dispos, 2000, 33 (3) :664 - 671.
7BERTZ RJ, GRANNEMAN GR. Use of in vitro and its vivo data to estimate the likelihood of metabolic pharmacokinetic interactions[J]. Clin Pharmacokinet, 1997. 32(2) :210 -258.
9WONG YN, K1NG SP, LAUGHTON WB, et al. Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers [ J ]. J Clin Pharmacol, 1998, 38(3) :276 -282.
10WONG YN, SIMCOE D, HARTMAN LN, et al. A double-blind, placebo-controlled, ascending-dose evaluation of pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers[J]. J Clin Pharmacol,1999,39(1):30-40.
